Different indications of photodynamic therapy in ophthalmology;Verschiedene Indikationen der photodynamischen Therapie in der Augenheilkunde

Klinische Monatsblatter fur Augenheilkunde

Volumn 226, Issue 9, 2009, Pages 725-739

  Lang, G E ^a   Mennel, S ^b   Spital, G ^c   Wachtlin, J ^d   Jurklies, B ^e   Heimann, H ^f   Damato, B ^f   Meyer, C H ^g  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c ST FRANZISKUS HOSPITAL   (Germany)

^d Sankt Gertrauden Krankenhaus   (Germany)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

^f ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^g UNIVERSITY OF BONN   (Germany)

Author keywords

Central serous chorioretionpathy; Choroidal malignant melanoma; Haemangioma; Idiopathic CNV; Photodynamic therapy; Uveitis

Indexed keywords

LOW DENSITY LIPOPROTEIN; TRIAMCINOLONE; VASCULOTROPIN INHIBITOR; VERTEPORFIN;

BACKACHE; BRACHYTHERAPY; CENTRAL SEROUS RETINOPATHY; CHOROIDITIS; CLINICAL ASSESSMENT; DISEASE COURSE; DRUG HYPERSENSITIVITY; EXUDATE; EYE DISEASE; HEMANGIOMA; HUMAN; LASER COAGULATION; MELANOMA; MINIMALLY INVASIVE PROCEDURE; MORPHOLOGY; MYOPIA; OPHTHALMOLOGY; PATHOGENESIS; PHOTODYNAMIC THERAPY; PORPHYRIA; PROGNOSIS; PROTON THERAPY; RADIOTHERAPY; RETINITIS; REVIEW; SUBRETINAL NEOVASCULARIZATION; TRANSPUPILLARY THERMOTHERAPY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VISUAL ACUITY;

EID: 77949456848     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1109514     Document Type: Review

References (60)

1. Mennel S, Barbazetto I, Meyer C H. et al. Ocular photodynamic therapy standard applications and new indications (part 1). Review of the literature and personal experience. Ophthalmologica 2007 221 216-226
2. Mennel S, Barbazetto I, Meyer C H. et al. Ocular photodynamic therapy standard applications and new indications (Part 2). Review of the literature and personal experience. Ophthalmologica 2007 221 282-291
3. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-TAP report No. 2. Arch Ophthalmol 2001 119 198-207
4. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularzation in patients with age-related macular degeneration. Additional information regarding baseline lesion compositions impact on vision outcomes-TAP report No. 3. Arch Ophthalmol 2002 120 1443-1454
5. Verteporfin in Photodynamic Therapy (VIP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. Ophthalmology 2001 108 841-852
6. Blinder K J., Blumenkranz M S., Bressler N M. et al. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial VIP report no. 3. phthalmology 2003 110 667-673
7. Husain D, Miller J W., Michaud N et al. Intravenous infusion of lipososmal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascualrization. Arch Ophtahlmol 1996 114 978-985
8. Richter A W., Waterfield E, Jain A K. et al. Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), in tumor tissue in a mouse tumor model. Photochem Photobiol 1993 57 1000-1006
9. Schmidt-Erfurth U, Hasan T, Gragoudas E et al. Vascular targeting in photodynamic occlusion of subretinal vessls. Ophthalmology 1994 101 1953-1961
10. Miller J W., Walsh A W., Kramer M et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol 1995 113 810-818
11. Kramer M, Miller J W., Michaud N et al. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys. Ophthalmology 1996 103 427-438
12. Fingar V H., Wilman T J., Wiehle S A. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction permeability and leukocyte adhesion. Cancer Res 1992 52 4914-4921
13. Cohen S Y., Laroche A, Leguen Y et al. Etiology of choroidal neovascularization in young patients. Ophthalmology 1996 103 1241-1244
14. Ho A C., Yannuzzi L A., Pisicano K et al. The natural history of idiopathic subfoveal choroidal neovascularization. Ophthalmology 1995 102 782-789
15. Chan W M., Lam D S., Wong T H. et al. Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series. Ophthalmology 2003 110 2395-2402
16. Wachtlin J, Wehner A, Heimann H et al. Photodynamic treatment with verteporfin for patients with idiopathic choroidal neovascularization. Two-year results. Ophthalmologe 2004 101 489-495
17. Su Z A., Yao K, Shen J et al. Evaluation of photodynamic therapy in idiopathic choroidal neovascularization. Zhonghua Yan Ke Za Zhi 2007 43 509-13
18. Chan W M., Lai T Y., Lau T T. et al. Combined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: one-year results of a prospective series. Retina 2008 28 71-80
19. Brown J Jr, Folk J C., Reddy C V. et al. Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ophthalmology 1996 103 (7) 1100-1105
20. Spaide R F., Freund K B., Slakter J et al. Treatment of subfoveal choroidal neovascularization associated with multifocal choroiditis and panuveitis with photodynamic therapy. Retina 2002 22 (5) 545-9
21. Shah G K., Blinder K J., Hariprasad S M. et al. Photodynamic therapy for juxtafoveal choroidal neovascularization due to ocular histoplasmosis syndrome. Retina 2005 25 (1) 26-32
22. Wachtlin J, Heimann H, Behme T et al. Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory Chororetinal diseases. Graefes Arch Clin Exp Ophthalmol 2003 241 (11) 899-906
23. Gerth C, Spital G, Lommatzsch A et al. Photodynamic therapy for choroidal neovascularization in patients with multifocal choroiditis and panuveitis. Eur J Ophthalmol 2006 16 (1) 111-118
24. Saperstein D A., Rosenfeld P J., Bressler N M. et al. Verteporfin therapy for CNV secondary to OHS. Ophthalmology 2006 113 (12) 2371 e1-3
25. Rechtman E, Allen V D., Danis R P. et al. Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndrome. Am J Ophthalmol 2003 136 (4) 739-741
26. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Arch Ophthalmol 1989 107 (3) 344-352
27. Hawkins B S., Bressler N M., Bressler S B. et al. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: I. Ophthalmic findings from a randomized clinical trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9. Arch Ophthalmol 2004 122 (11) 1597-1611
28. Chan W M., Lai T Y., Liu D T. et al. Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol 2007 143 (6) 977-983
29. Bakri S J., Larson T A., Edwards A O. Intraocular inflammation following intravitreal injection of bevacizumab. Graefes Arch Clin Exp Ophthalmol 2008 246 (5) 779-781
30. Shields C L., Honavar S G., Shields J A. et al. Circumscribed choroidal hemangioma: clinical manifestations and factors predictive of visual outcome in 200 consecutive cases. Ophthalmology 2001 108 2237-2248
31. Schmidt-Erfurth U, Michels S, Kusserow C et al. Photodynamic therapy for symptomatic choroidal hemangioma: Visual and anatomic results. Ophthalmology 2002 109 2284-2294
32. Michels S, Michels B, Simader C et al. Verteporfin therapy for choroidal hemangioma: a long-term follow-up. Retina 2005 25 697-703
33. Jurklies B, Anastassiou G, Ortmans S et al. Photodynamic therapy using Verteporfin in circumscribed choroidal hemangioma. Br J Ophthalmol 2003 87 84-89
34. Verbraak F D., Schlingemann R O., Keunen J E. et al. Longstanding symptomatic choroidal hemangioma managed with limited PDT as initial or salvage therapy. Graefes Arch Clin Exp Ophthalmol 2003 241 891-898
35. Singh A D., Kaiser P K., Sear J E. et al. Photodynamic therapy of circumscribed choroidal hemangioma. Br J Ophthalmol 2004 11 1414-1418
36. Verbraak F D., Schlingemann R O., de Smet M D. et al. Single spot PDT in patients with circumscribed choroidal hemangioma and near normal visual acuity. Graefes Arch Clin Exp Ophthalmol 2006 244 1178-1182
37. Bosch M M., Helbig H. Blackening of a choroidal hemangioma after photodynamic therapy. Klin Monatsbl Augenheilkd 2005 22 258-260
38. Damato B, Elizalde J, Heimann H. Vasoproliferative Retinal Tumor. Joussen AM, Gardner TW, Kirchhof B, Ryan SJ Retinal Vascular Disease Berlin, Heidelberg, New York Springer-Verlag 2007 766-770
39. Damato B. Vasoproliferative retinal tumour. Br J Ophthalmol 2006 90 399-400
40. Heimann H, Bornfeld N, Vij O et al. Vasoproliferative tumours of the retina. Br J Ophthalmol 2000 84 1162-1169
41. Shields C l, Shields J A., Barrett J et al. Vasoproliferative tumors of the ocular fundus. Classification and clinical manifestations in 103 patients. Arch Ophthalmol 1995 113 615-623
42. Barbezetto I A., Smith R T. Vasoproliferative tumor of the retima treated with PDT. Retina 2003 23 565-567
43. Blasi M A., Scupola A, Tiberti A C. et al. Photodynamic therapy for vasoproliferative retinal tumors. Retina 2006 26 404-409
44. Osman S a, Aylin Y, Arikan G et al. Photodynamic treatment of a secondary vasoproliferative tumour associated with sector retinitis pigmentosa and Usher syndrome type I. Clin Experiment Ophthalmol 2007 35 191-193
45. Rodriguez-Coleman H, Spaide R F., Yannuzzi L A. Treatment of angiomatous lesions of the retina with photodynamic therapy. Retina 2002 22 228-232
46. Saldanha M J., Edrich C. Treatment of vasoproliferative tumors with photodynamic therapy. Ophthalmic Surg Lasers Imaging 2008 39 143-145
47. Damato B. Developments in the management of uveal melanoma. Clin Experiment Ophthalmol 2004 32 639-647
48. Barbazetto I A., Lee T C., Rollins I S. et al. Treatment of choroidal melanoma using photodynamic therapy. Am J Ophthalmol 2003 135 898-899
49. Donaldson M J., Lim L, Harper C A. et al. Primary treatment of choroidal amelanotic melanoma with photodynamic therapy. Clin Experiment Ophthalmol 2005 33 548-549
50. Soucek P, Cihelkova I. Photodynamic therapy with verteporfin in subfoveal amelanotic choroidal melanoma (A controlled case). Neuro Endocrinol Lett 2006 27 145-148
51. Wachtlin J, Bechrakis N E., Foerster M H. Photodynamic therapy with verteporfin for uveal melanoma. Ophthalmologe 2005 102 241-246
52. Bruce R A Jr. Evaluation of hematoporphyrin photoradiation therapy to treat choroidal melanomas. Lasers Surg Med 1984 4 59-56
53. Tse D T., Dutton J J., Weingeist T A. et al. Hematoporphyrin photoradiation therapy for intraocular and orbital malignant melanoma. Arch Ophthalmol 1984 02 833-838
54. Gonzalez V H., Hu L K., Theodossiadis P G. et al. Photodynamic therapy of pigmented choroidal melanomas. Invest Ophthalmol Vis Sci 1995 36 871-878
55. Kim R Y., Hu L K., Foster B S. et al. Photodynamic therapy of pigmented choroidal melanomas of greater than 3-mm thickness. Ophthalmology 1996 103 2029-2036
56. Kitzmann A S., Pulido J SM, Diehl N N. et al. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980 2002. Ophthalmology 2008 115 169-173
57. Valmaggia C, Niederberger H. Photodynamic therapy in the treatment of chronic central serous chorioretinopathy. Klin Monatsbl Augenheilkd 2006 223 372-375
58. Mennel S, Peter S, Meyer C H. et al. Effect of photodynamic therapy on the function of the outer blood-retinal barrier in an in vitro model. Graefes Arch Clin Exp Ophthalmol 2006 244 1015-1021
59. Chan W M., Lai T YY, Lai R YK et al. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy. Retina 2008 28 85-93
60. Chan W M., Lai T Y., Lai R Y. et al. Half-Dose Verteporfin Photodynamic Therapy for Acute Central Serous Chorioretinopathy One-Year Results of a Randomized Controlled Trial. Ophthalmology 2008 115 1756-1765